TRIM17 and osteosarcoma: Therefore, our assayal results suggest that TRIM17 regulates the expression of PDK1 through FTO-mediated m6A demethylation in osteosarcoma, and further activates downstream AKT/mTOR signaling pathway activity to positively regulate the malignancy of osteosarcoma.